One study by Ueno et al. has suggested that elevated adiponectin levels are linked to the absence of LVSI in endometrial cancer tissues, implying a potential protective role of adiponectin against lymphovascular invasion [74]. Here, ADIPOQ is linked to endometrial cancer.